SARAJEVO (Bosnia and Herzegovina), March 2 (SeeNews) – Bosnian pharmaceuticals maker Bosnalijek [SAJ:BSNLR] said on Thursday its pre-tax profit increased 6% on the year to 11.8 million marka ($6.3 million/6 million euro) in 2016.